Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dantzig

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Molecular Pharmacology|April 19, 2002
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoproteinSean Ekins, Richard B Kim, Brenda F Leake, et al.
Molecular Pharmacology|April 19, 2002
Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substratesSean Ekins, Richard B Kim, Brenda F Leake, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146B H Norman, A H Dantzig, J S Kroin, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1)Bryan H Norman, Joseph M Gruber, Sean P Hollinshead, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1)Bryan H Norman, Peter A Lander, Joseph M Gruber, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|September 11, 2007
The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapyAnnemieke H M Jansen, Frank Bracke, Jan Melle van Dantzig, et al.
Advances in Enzyme Regulation|January 1, 1997
Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoproteinJ J Starling, R L Shepard, J Cao, et al.
The American Journal of Cardiology|April 3, 2007
Qualitative observation of left ventricular multiphasic septal motion and septal-to-lateral apical shuffle predicts left ventricular reverse remodeling after cardiac resynchronization therapyAnnemieke H M Jansen, Jan melle van Dantzig, Franck Bracke, et al.
Cancer Research|August 3, 2005
Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulatorsWilliam L Perry, Robert L Shepard, Janardhan Sampath, et al.
Journal of Medicinal Chemistry|October 29, 2009
Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabineDavid M Bender, Jingqi Bao, Anne H Dantzig, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Molecular Pharmacology|April 19, 2002
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoproteinSean Ekins, Richard B Kim, Brenda F Leake, et al.
Molecular Pharmacology|April 19, 2002
Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substratesSean Ekins, Richard B Kim, Brenda F Leake, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146B H Norman, A H Dantzig, J S Kroin, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1)Bryan H Norman, Joseph M Gruber, Sean P Hollinshead, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1)Bryan H Norman, Peter A Lander, Joseph M Gruber, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|September 11, 2007
The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapyAnnemieke H M Jansen, Frank Bracke, Jan Melle van Dantzig, et al.
Advances in Enzyme Regulation|January 1, 1997
Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoproteinJ J Starling, R L Shepard, J Cao, et al.
The American Journal of Cardiology|April 3, 2007
Qualitative observation of left ventricular multiphasic septal motion and septal-to-lateral apical shuffle predicts left ventricular reverse remodeling after cardiac resynchronization therapyAnnemieke H M Jansen, Jan melle van Dantzig, Franck Bracke, et al.
Cancer Research|August 3, 2005
Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulatorsWilliam L Perry, Robert L Shepard, Janardhan Sampath, et al.
Journal of Medicinal Chemistry|October 29, 2009
Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabineDavid M Bender, Jingqi Bao, Anne H Dantzig, et al.
Pageof 19